AspenBio Pharma (APPY)
AspenBio Pharma Gross Profit Margin: 97.26%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
APPY Gross Profit Margin Rankings
| Overall | 98th percentile | 46 of 3914 |
| Sector | 98th percentile | 7 of 368 in Healthcare |
| Industry | 92nd percentile | 1 of 13 in Diagnostic Substances |
APPY Gross Profit Margin Range, Past 5 Years
| Minimum | -1865% | Dec 2009 |
| Maximum | 98.50% | Dec 2011 |
| Average | -68.72% |
About Gross Profit Margin
Gross profit margin is the difference between sales and the cost of goods sold divided by revenue. It expresses the relationship between gross profit (sales - cost of goods sold) and sales revenue. More specifically, gross profit margin represents the percentage of each dollar of a company's revenue that is available to cover fixed costs after paying for the goods or services that were sold.
If a company produces widgets and earns $32 million in sales but pays $24 million for the items sold, then the company's gross profit margin would be ($32m - $24m)/$32m = %25.
Learn More
You may also be interested in these APPY related companies
APPY News
$APPY filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3H0d
about 48 days ago by MarketBrief
about 48 days ago by MarketBrief
AspenBio Pharma (APPY) Presents Encouraging Data for AppyScore from 503-Patient Pilot Study
Mar 16, 2:17PM Street Insider
Mar 16, 2:17PM Street Insider
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (APPY); Not Losing Sight of Big Picture
Feb 22, 10:21AM Street Insider
Feb 22, 10:21AM Street Insider
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (AAPY); Multi-marker Panel Likely Key to Approval & Uptake
Jan 24, 8:52AM Street Insider
Jan 24, 8:52AM Street Insider
$APPY Announces Registered Direct Offering of Approximately $1.6 Million
about 152 days ago by Benzinga
about 152 days ago by Benzinga
AspenBio Pharma reports data from AppyScore pilot and planned product pathway
Nov 28, 4:18PM FlyOnTheWall
Nov 28, 4:18PM FlyOnTheWall
AspenBio Reports Data From AppyScore Pilot Study and Planned Product Pathway
Nov 28, 4:15PM Benzinga
Nov 28, 4:15PM Benzinga
AspenBio Reports Interim Data From AppyScore Pilot Study and Outlook for Regulatory Pathway
Oct 19, 4:05PM Marketwire
Oct 19, 4:05PM Marketwire
AspenBio Pharma to Hold Investor Update Call on Wednesday, October 19, 2011 at 4:30 p.m. ET
Oct 17, 6:25PM Marketwire
Oct 17, 6:25PM Marketwire
$APPY $0.75 Mkt Cap $30,103,740 offering $15,000,000 (50% dilution) in common shs, warrants
about 379 days ago by canarionyc
about 379 days ago by canarionyc
Content with holding $urg under 3. $appy is holding up nicely, looking to have another bite in the morning.
about 494 days ago by CRPowers
about 494 days ago by CRPowers
Another bite of $appy .6295 for a .675 avg. I like the way it is holding above .60
about 494 days ago by CRPowers
about 494 days ago by CRPowers
@mb_willoughby @wibiya Nice post MB. Like the looks of $APPY tomorrow. Great find. $$
about 495 days ago by kidspouseme
about 495 days ago by kidspouseme
$APPY: the fun appears to be over. whoever got out, got out. 5 million shares traded. Insider victory party in Castle Rock tonight. lol.
about 579 days ago by BiotechtraderHB
about 579 days ago by BiotechtraderHB
$APPY: back from the dead? big volume again. news on appyscore -- be careful with this one...
about 579 days ago by BiotechtraderHB
about 579 days ago by BiotechtraderHB
Congrats to those that played $APPY today from last nights Alert. 50% Gain! Low of .35 closing hod at .57 http://bit.ly/dfJ5NO $$
about 580 days ago by ManicTrader
about 580 days ago by ManicTrader
$APPY http://chart.ly/q5urrdq Picks to Radar~ $APPY Aspen bio pharma Looking sweet
about 581 days ago by ManicTrader
about 581 days ago by ManicTrader
@DigDugTrader FYI Michael Vlaicu is a penny stock promoter $FAZ $APPY
about 657 days ago by j_remington
about 657 days ago by j_remington
I had some fun w. $APPY and its penchant for making excuses to explain clinical trial blowups --> http://bit.ly/aIgwhI
about 677 days ago by adamfeuerstein
about 677 days ago by adamfeuerstein
this morning started small positions $ANV 19.33 $AAPL 257.59 $ISLN 14.59 $APPY 3.59
about 740 days ago by CumbucoTrader
about 740 days ago by CumbucoTrader
Meant $ACAS, NOT $APPY: Nice buying opp on $APPY this AM on the dip below $6 considering earnings and JPMorgan upgrade. NAV is tickling $9
about 753 days ago by wesleydrake30
about 753 days ago by wesleydrake30
Nice buying opp on $APPY this AM on the dip below $6 considering solid earnings and JPMorgan upgrade. NAV is tickling $9
about 753 days ago by wesleydrake30
about 753 days ago by wesleydrake30
$APPY Sold June 2.50 puts @ .45 bought at .35. A decent gain...still think it has more room to go to 3.25
about 754 days ago by silviaracer
about 754 days ago by silviaracer
SELLING entire $APPY position Monday. Taking profits to POZN. Staying LONG & ADDING more to POZN Monday Pre-Market. POZN Received Approval!
about 757 days ago by FloridaGators
about 757 days ago by FloridaGators
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| APPY | 0.62 | -0.02 | -3.12% | 5.971M |
| APP | 0.8505 | -0.01 | -1.68% | 89.86M |
| APOL | 33.12 | +0.61 | +1.88% | 4.170B |
| APOG | 14.97 | -0.02 | -0.13% | 419.46M |
| AON | 47.39 | +0.04 | +0.08% | 15.41B |
| AOL | 27.48 | -0.13 | -0.47% | 2.605B |
| ANX | 0.535 | -0.01 | -0.93% | 25.53M |
| ANW | 5.27 | +0.01 | +0.19% | 243.63M |
| ANV | 27.47 | -0.20 | -0.72% | 2.463B |
| ASEI | 49.46 | +1.29 | +2.68% | 441.18M |
